Prof. June Corry

  • MBBS, FRACP, FRANZCR, MD
  • Radiation Oncologist
  • Spoken languages English

Overview

I thrive on the complexity and high degree of difficulty required to successfully treat patients with head and neck cancer.

Research interests

Clinical research is the way we improve future outcomes for patients – from better treatments to better patient support during and after cancer treatment.

Professional memberships

  • Royal Australian College Physicians
  • Royal Australian New Zealand College Radiologists
  • American Society Therapeutic Radiology and Oncology (ASTRO)
  • ANZ Head& Neck Society (ANZHNS) – President 2008
  • Head & Neck cancer committee, Victorian Cooperative Oncology Group (VCOG) – Chair 2004-2008.
  • Executive Committee member Trans- Tasman Radiation Oncology Group TROG)
  • Chair, TROG H&N committee
  • Founding Member of the International Academy of Oral Oncology (IAOO)
  • International Atomic Energy Agency (IAEA) NPC subcommittee member

Publications and affiliations

  • Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, et al. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.  Int J Radiat Oncol Biol Phys. 2020 Apr 14. pii: S0360-3016(20)31034-8. doi: 10.1016/j.ijrobp.2020.04.016. [Epub ahead of print]
  • Lee AW, Ng WT, Pan JJ, Chiang CL, Corry J, Wee JT. International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning Of Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019 Nov 1;105(3):567-580. doi: 10.1016/j.ijrobp.2019.06.2540. Epub 2019 Jul 2.
  • Corry J. Collaborative action will generate better outcomes. Lancet Oncol. 2018 Mar;19(3):278-280. JIF: 36.418.
  • Corry J, Peters LJ, Rischin D. The Impact of Center Size and Experience on Outcomes in Head and Neck Cancer. J Clin Oncol 2015; 33:138-140. JIF: 26.303.
  • Corry J, Peters L, Kleid S, Rischin D. Larynx preservation for patients with locally advanced laryngeal cancer. J Clin Oncol. 2013 Mar 1;31(7):840-4. JIF: 26.303.